Researchers from NIMHANS, Bengaluru, have shed new light on early molecular events that can cause Parkinson’s disease, proposing a shift from the conventional theory that has guided drug development for decades. Their research has suggested that disease-specific chemical changes in α-Synuclein (αSyn) – a protein strongly linked to Parkinson’s disease – may promote the capture […]
